DLBCL
Conference Coverage
Survey quantifies COVID-19’s impact on oncology
Oncologists detail how COVID-19 has impacted care, caregivers, continuing medical education, and clinical trials.
News
FDA approves new drug for diffuse large B-cell lymphoma
From the Journals
HSCT or systemic treatment should be offered to HIV+ patients with lymphoma
News
FDA approves selinexor for relapsed/refractory DLBCL
Conference Coverage
Adding avadomide shows promise for newly diagnosed DLBCL
From the Journals
Race and location appear to play a role in the incidence of CLL and DLBCL
From the Journals
DLBCL patients at academic centers had significantly better survival
Researchers suggested that academic centers might provide increased access to clinical trials, improved physician expertise, improved treatment...
From the Journals
Safer CAR uses modified NK cells for advanced CLL, NHL
From the Journals
DLBCL tops cases of HBV-associated NHL in Europe
Conference Coverage
REGN1979 shows good activity in pretreated aggressive B-NHL
...
Guidelines
NCCN guidelines highlight ‘complicated’ treatment for pediatric lymphomas
The guidelines include recommendations for managing pediatric Burkitt lymphoma and diffuse large B-cell lymphoma.